University of Cambridge

Cambridge CB4 1PR

3 studies enrolling now · 13 studies all time

What they study most

Angelman Syndrome, Autoimmune Diseases, Barrett's Esophagus, Bone Marrow Disease, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Clinical High Risk, Conversion, Diabetes Mellitus, Diabetes Mellitus, Type 1, Dysplasia, Endocrine System Diseases

Studies at this site

• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway — Completed
• A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants — Running, not enrolling
• Long-term Extension of GTX-102 in Angelman Syndrome — Enrolling by invitation
• A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies — Completed
• A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity — Completed
• A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO) — Enrolling by invitation
• AMP SCZ® Observational Study: PREDICT-DPACC — Running, not enrolling
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) — Running, not enrolling
• DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway — Completed
• NA-AION Risk Factors: New Perspectives — Completed
• Home Testing of Day and Night Closed Loop With Pump Suspend Feature — Completed
• Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management — Completed